In mice with dilated cardiomyopathy, pharmacologic antagonism of stromal cell-derived factor-1/CXCR4 signaling with AMD3100 was shown to decrease splenic CD4 + T cell abundance and cardiac fibrosis and improve diastolic and systolic myocardial performance [21]. Here, CXCL12 is linked to dilated cardiomyopathy.